Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Minocin
MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort.
The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes.
Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function.
Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72.
TAPP1 inhibits the differentiation of oligodendrocyte precursor cells via suppressing the Mek/Erk pathway.
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy.
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Fampridine – Benefit assessment according to § 35a Social Code Book V
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
In vitro assessment of the direct effect of laquinimod on basic functions of human neural stem cells and oligodendrocyte progenitor cells.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.
Role of statins in the treatment of multiple sclerosis.
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.
Extension Trial Data Shows Cladribine Benefits Persist in RRMS Patients
N-Acetylcysteine amide: A Derivative to Fulfill the Promises of N-Acetylcysteine.
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications

Pages